GSK plc
GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
45 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$39.36
Price+1.44%
$0.56
1Y
Price
Market Cap
$80.260b
Large
Price/Earnings 3y Avg5y Avg
17.7x
Premium
Premium
Financials Overview
Key metrics over the past few years+40.5%
EBITDA Margin+18.1%
Net Profit Margin+18.3%
Free Cash Flow MarginRevenue
$31.631b
+0.8%
1y CAGR+2.6%
3y CAGR-1.6%
5y CAGREarnings
$3.423b
+32.9%
1y CAGR-4.9%
3y CAGR-0.6%
5y CAGREPS
$1.65
+33.1%
1y CAGR-5.1%
3y CAGR-6.6%
5y CAGRBook Value
$14.354b
$59.258b
Assets$44.904b
Liabilities-
DebtDebt to Assets
0.0%
-
Debt to EBITDAFree Cash Flow
$4.666b
+30.6%
1y CAGR-0.9%
3y CAGR+0.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in GBP.No items found.
Press Releases
Statements and updates from the company